We discovered that the combination of AH057 and a DNMT1 inhibitor SGI-1027 displayed strong synergistic antitumor effect against CC cells, raising the possibility that synergistically targeting JAK/STAT and DNMT1 might be a promising strategy for effectively treating CC and other human cancers. Here, DNMT1 is linked to cancer.